Compare VOXR & MOBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VOXR | MOBI |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 355.5M | 383.0M |
| IPO Year | 2022 | 2026 |
| Metric | VOXR | MOBI |
|---|---|---|
| Price | $5.60 | $10.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.90 | N/A |
| AVG Volume (30 Days) | ★ 407.2K | 154.9K |
| Earning Date | 05-08-2026 | N/A |
| Dividend Yield | ★ 1.01% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $60.51 | N/A |
| Revenue Next Year | $44.51 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.44 | $10.01 |
| 52 Week High | $6.70 | $15.19 |
| Indicator | VOXR | MOBI |
|---|---|---|
| Relative Strength Index (RSI) | 56.50 | 39.10 |
| Support Level | $4.81 | N/A |
| Resistance Level | $5.86 | $12.28 |
| Average True Range (ATR) | 0.20 | 0.84 |
| MACD | -0.02 | -0.12 |
| Stochastic Oscillator | 50.00 | 6.02 |
Vox Royalty Corp is a returns-focused mining royalty and streaming company. It holds a diversified portfolio of several royalties and streams, including producing and development stage assets, with primary exposure to gold and select industrial metals across top-tier mining jurisdictions. Vox is organized into two operating segments, consisting of acquiring and managing royalty interests; and acquiring and managing streams and other interests. Maximum revenue is generated from its Royalty Interests segment. The majority of the company's portfolio of royalty, streams, and other interests by asset count is located in Australia, Canada, and the United States, of which the maximum revenue is derived from its assets in Australia.
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.